|Mario C. Raviglione|
Mario Raviglione, Director of the WHO Global TB Programme
|Alma mater||University of Turin|
|Occupation||Global health expert and former Director of the World Health Organization Global TB Programme|
|Spouse(s)||Angela Paraluppi Raviglione|
Mario C. Raviglione is a global health expert. He was Director of the Global Tuberculosis Programme at the World Health Organization (WHO) between 2003 and 2017. He graduated in Medicine from the University of Turin in 1980 and then trained in internal medicine and Infectious Diseases at Cabrini Medical Center in New York City and at Beth Israel Medical Center in Boston. Back in Europe, Raviglione joined WHO in 1991 as a Junior Professional Officer, and spent a few years working on TB and AIDS, TB epidemiology in Europe, and anti-TB drug resistance surveillance and response. In the mid-1990s, he set up both the WHO global drug resistance surveillance project and the WHO global TB surveillance and monitoring systems . Among his achievements are the contributions to the development of the WHO's DOTS Strategy in 1995, and the direction of the development of both the Stop TB Strategy in 2006  and the End TB Strategy in 2014 . During his years at WHO he worked with, and visited, more than 50 countries supporting their TB care, prevention, control and research activities. His research work has resulted in over 350 scientific articles and chapters on the topics of infectious diseases, HIV/AIDS, TB, and global health, including chapters in Harrison's Principles of Internal Medicine. He is editor of the 3rd and 4th (2006, 2009) edition of "Tuberculosis - A comprehensive international approach", a multi-author book, and associate editor of other books on public health, infectious diseases and tuberculosis. He is among the top 10 most cited authors in the TB field. His h-index is 96 and his work has been cited over 40,000 times . He is also among the top 20 italian epidemiological scientists and the top 100 italian scientists in general . As an expert in TB, he has worked as a visiting professor at Johns Hopkins University, University of Geneva, University of Modena and Reggio Emilia, and University of Pavia. He is currently visiting professor at the University of Brescia and has recently lectured at major universities including Harvard, Mc Gill and Sydney. He participates in a variety of scientific and advisory committees, including those of the TB Alliance, Doctors with Africa CUAMM, BE Health Association, and Fondazione 3Bi.. In 2017 he has been asked to become member of the Lancet Commission on TB. In the past two years he has conceived and co-organised, with WHO and Russian colleagues, the first Global WHO Ministerial Conference on TB in the Sustainable Development Era, held in Moscow on 16-17 November 2017, and his team has worked towards ensuring that TB is raised in the international political agenda through the United Nations General Assembly high-level meeting on TB to be held in 2018 .
In 2005, Dr Raviglione received the Princess Chichibu TB Global Award for his achievements in TB control. In 2009 he was nominated Fellow of the Royal College of Physicians (F.R.C.P., London, UK). In 2010, he received the Wolfheze 20 Year Jubilee Award for his contributions to modern TB control practices in Europe. In 2014, he was appointed a Foundation Fellow of the European Respiratory Society (F.E.R.S.). In 2014, he received the Lifetime Achievement Award by the India International Public Health Conference of the Indian Medical Association. In 2016 he was made Honorary Member of the Russian Society of Phtisiatry and in 2017 he received the USAID Global Leader Award "in recognition of innovative approach, scientific rigor, and dedicated service in partnership to End TB" .